Palisade Bio granted new employee option to purchase 2,600 shares

From GlobeNewswire: 2025-01-03 17:20:00

Palisade Bio, Inc. (Nasdaq: PALI) granted a new employee an option to purchase 2,600 shares of the company’s common stock as an inducement for employment. The option was issued on January 3, 2025, with an exercise price based on the closing price of the stock on that date. Vesting of the option occurs quarterly over three years, contingent on the employee providing services to the company. Palisade Bio focuses on developing therapeutics for autoimmune, inflammatory, and fibrotic diseases, aiming to revolutionize treatment options. For more information, visit www.palisadebio.com. Investors can contact JTC Team, LLC at [email protected] for inquiries.



Read more at GlobeNewswire: Palisade Bio Announces Inducement Grant Under Nasdaq